Riociguat in Children With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT02562235 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02562235
Sponsor: Bayer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2015-10-29
Primary completion: 2020-03-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.